You are here
AdvaMedDx Executive Director Andrew Fish testified before the U.S. House of Representatives Energy and Commerce Committee in support of FDA taking a risk-based approach to the regulation of lab-dev... more
AdvaMedDx held a Capitol Hill briefing on the life-saving role of diagnostics and devices to ensure that the U.S. blood suppl... more
AdvaMedDx partnered with the American Cancer Society Cancer Action Network (ACS CAN), the Association of Communit... more
AdvaMedDx, the European Diagnostics Manufacturers Association (EDMA), and the Global Medical Technology Alliance (GMTA) he... more
As part of its service to members, AdvaMedDx launched the U.S. Market Statistics Survey in 2013. The survey complements the Global Diagnostic Market Statistics program developed by the European Dia... more
AdvaMedDx and the Centers for Disease Control and Prevention (CDC) collaborated on an infectious disease bri... more
AdvaMedDx partnered with the American Association for Cancer Research to organize a day-long symposium focused on cancer diagnostics. "Transforming Cancer Care Through Diagnostics and Personalized... more
Dx Insights and AdvaMedDx hosted a webinar on the “Essentials of Diagnostics: Introduction to Molecular Diagnostics” report... more
AdvaMedDx hosted a Capitol Hill briefing on the topic of antibiotic resistance on Monday, June 3rd. Antibiotic resistance is quickly becoming one of the world's most pressing health problems. Drug... more
AdvaMedDx, the European Diagnostics Manufacturers Association (EDMA), and the Global Medical Technology Alliance (GMTA) held our second annual diagnostics briefing at the World Health Assembly. Thi... more